Medical abortion in the late first trimester: a systematic review
- PMID:30444970
- PMCID: PMC6367561
- DOI: 10.1016/j.contraception.2018.11.002
Medical abortion in the late first trimester: a systematic review
Abstract
Objective: To describe the efficacy, safety, and acceptability of medical abortion in the late first trimester.
Study design: We searched PubMed and Cochrane databases for articles in any language that examined the success of medical abortion at gestational ages (>63 to≤84 days gestation). We sought articles that compared: medical abortion with surgical abortion at this gestational age, combination mifepristone and misoprostol and/or misoprostol alone); different dosages of misoprostol; different routes of misoprostol administration; frequency of dosing; and location of medical abortion (in health care facility vs. outpatient management). Our primary outcome was complete abortion. Data was independently abstracted by two authors, graded for evidence quality, and assessed for risk of bias.
Results: The search strategy returned 3384 articles, nine of which met inclusion criteria. Medical abortion, as compared with surgical abortion, was effective in the late first trimester (94.6% versus 97.9% complete abortion). A combined regimen of mifepristone and misoprostol was significantly more effective than misoprostol alone (90.4 versus 81.6% complete abortion). Complete abortion rates for all regimens investigated ranged from 78.6% to 94.6%. Success rates were higher with repeat dosing of misoprostol both in combination regimens and alone, and with vaginal compared with oral administration for repeat dosing.
Conclusion: A limited body of evidence indicates a range of efficacy of medical abortion in the late first trimester and highlights the need for well-designed trials in this gestational age range.
Implications: This review highlights the need for research focused on the late first trimester to strengthen the body of evidence. The available evidence is limited but offers reassurance that adverse events are rare for later first trimester abortion. Importantly, new research demonstrates that efficacy remains unchanged in the 10th gestational week regardless of whether the medication is taken in a facility or at a woman's home.
Keywords: Late medical abortion; Medical abortion efficacy; Mifepristone; Misoprostol.
Copyright © 2018 The Author(s). Published by Elsevier Inc. All rights reserved.
Similar articles
- Medical methods for first trimester abortion.Kulier R, Gülmezoglu AM, Hofmeyr GJ, Cheng LN, Campana A.Kulier R, et al.Cochrane Database Syst Rev. 2004;(2):CD002855. doi: 10.1002/14651858.CD002855.pub3.Cochrane Database Syst Rev. 2004.Update in:Cochrane Database Syst Rev. 2011 Nov 09;(11):CD002855. doi: 10.1002/14651858.CD002855.pub4.PMID:15106180Updated.Review.
- Medical methods for first trimester abortion.Kulier R, Gülmezoglu AM, Hofmeyr GJ, Cheng LN, Campana A.Kulier R, et al.Cochrane Database Syst Rev. 2004;(1):CD002855. doi: 10.1002/14651858.CD002855.pub2.Cochrane Database Syst Rev. 2004.Update in:Cochrane Database Syst Rev. 2004;(2):CD002855. doi: 10.1002/14651858.CD002855.pub3.PMID:14973995Updated.Review.
- Efficacy of medical abortion prior to 6 gestational weeks: a systematic review.Kapp N, Baldwin MK, Rodriguez MI.Kapp N, et al.Contraception. 2018 Feb;97(2):90-99. doi: 10.1016/j.contraception.2017.09.006. Epub 2017 Sep 18.Contraception. 2018.PMID:28935220
- Medical methods for first trimester abortion.Kulier R, Kapp N, Gülmezoglu AM, Hofmeyr GJ, Cheng L, Campana A.Kulier R, et al.Cochrane Database Syst Rev. 2011 Nov 9;2011(11):CD002855. doi: 10.1002/14651858.CD002855.pub4.Cochrane Database Syst Rev. 2011.Update in:Cochrane Database Syst Rev. 2022 May 24;5:CD002855. doi: 10.1002/14651858.CD002855.pub5.PMID:22071804Free PMC article.Updated.Review.
- Medical termination for pregnancy in early first trimester (≤ 63 days) using combination of mifepristone and misoprostol or misoprostol alone: a systematic review.Abubeker FA, Lavelanet A, Rodriguez MI, Kim C.Abubeker FA, et al.BMC Womens Health. 2020 Jul 7;20(1):142. doi: 10.1186/s12905-020-01003-8.BMC Womens Health. 2020.PMID:32635921Free PMC article.
Cited by
- Health Inequities Among People Who Use Drugs in a Post-Dobbs America: The Case for a Syndemic Analysis.Carroll JJ, Ostrach B, El-Sabawi T.Carroll JJ, et al.J Law Med Ethics. 2023;51(3):549-553. doi: 10.1017/jme.2023.96. Epub 2023 Dec 13.J Law Med Ethics. 2023.PMID:38088631Free PMC article.
- Aya Contigo: evaluation of a digital intervention to support self-managed medication abortion in Venezuela.Cleverley K, Sergeant A, Zamberlin N, Medina S, Tam G, Gill R.Cleverley K, et al.Front Glob Womens Health. 2024 Oct 17;5:1401779. doi: 10.3389/fgwh.2024.1401779. eCollection 2024.Front Glob Womens Health. 2024.PMID:39483289Free PMC article.
- Special ambulatory gynecologic considerations in the era of coronavirus disease 2019 (COVID-19) and implications for future practice.Cohen MA, Powell AM, Coleman JS, Keller JM, Livingston A, Anderson JR.Cohen MA, et al.Am J Obstet Gynecol. 2020 Sep;223(3):372-378. doi: 10.1016/j.ajog.2020.06.006. Epub 2020 Jun 6.Am J Obstet Gynecol. 2020.PMID:32522513Free PMC article.Review.
- Medical methods for first trimester abortion.Zhang J, Zhou K, Shan D, Luo X.Zhang J, et al.Cochrane Database Syst Rev. 2022 May 24;5(5):CD002855. doi: 10.1002/14651858.CD002855.pub5.Cochrane Database Syst Rev. 2022.PMID:35608608Free PMC article.Review.
- Commentary: No-test medication abortion: A sample protocol for increasing access during a pandemic and beyond.Raymond EG, Grossman D, Mark A, Upadhyay UD, Dean G, Creinin MD, Coplon L, Perritt J, Atrio JM, Taylor D, Gold M.Raymond EG, et al.Contraception. 2020 Jun;101(6):361-366. doi: 10.1016/j.contraception.2020.04.005. Epub 2020 Apr 16.Contraception. 2020.PMID:32305289Free PMC article.No abstract available.
References
- Rodriguez M.I., Seuc A., Kapp N. Acceptability of misoprostol-only medical termination of pregnancy compared with vacuum aspiration: an international, multicentre trial. BJOG. 2012;119:817–823. - PubMed
- Winikoff B., Sivin I., Coyaji K.J. Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion. Am J Obstet Gynecol. 1997;176:431–437. - PubMed
- Program of Action: Report of the International Conference on Population and Development, Cairo. 1994.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous